Home Editor's Picks Boeing and Former CEO to Pay $200 Million and $1 Million to Settle SEC Charges

Boeing and Former CEO to Pay $200 Million and $1 Million to Settle SEC Charges


Boeing and Former CEO to Pay $200 Million and $1 Million to Settle SEC Charges By Investing.com

Breaking News


Stock Markets 1 hour ago (Sep 22, 2022 05:16PM ET)

(C) Reuters. Boeing and Former CEO to Pay $200 Million and $1 Million to Settle SEC Charges

By Davit Kirakosyan

Today, The Securities and Exchange Commission charged The Boeing Company (NYSE:BA) and its former CEO, Dennis A. Muilenburg, with making materially misleading public statements following crashes of Boeing airplanes in 2018 and 2019.

According to the SEC’s orders, after the first crash, Boeing and Muilenburg knew that the Maneuvering Characteristics Augmentation System (MCAS) posed an ongoing airplane safety issue, but nevertheless assured the public that the 737 MAX airplane was safe. Following the second crash, the company and Muilenburg misled investors by providing assurances that there were no slips or gaps in the certification process with respect to MCAS, despite knowing about serious safety concerns.

The company and Muilenburg consented to cease-and-desist SEC orders that include penalties of $200 million and $1 million, respectively.

Boeing and Former CEO to Pay $200 Million and $1 Million to Settle SEC Charges

U.S. cutting global donations of Pfizer COVID shots as demand slowsBy Reuters – Sep 22, 2022

By Michael Erman NEW YORK (Reuters) – The United States is significantly cutting back the number of Pfizer/BioNTech COVID-19 vaccine doses it will buy for donation to poorer…

Chipmaker Qualcomm says automotive future business expands to $30 billionBy Reuters – Sep 22, 2022

By Jane Lanhee Lee and Akash Sriram (Reuters) -U.S. chip designer Qualcomm (NASDAQ:QCOM) Inc on Thursday said its automotive business “pipeline” increased to $30 billion, up more…

After-Hours Movers: Spectrum Pharm Sinks on Negative FDA Panel, Costco Dips on EPSBy Investing.com – Sep 22, 2022

After-Hours Stock Movers:
Spectrum Pharmaceuticals (NASDAQ:SPPI) 28% LOWER; The FDA’s Oncologic Drugs Advisory Committee (ODAC) met to review poziotinib for the treatment of…

Our Apps

Terms And Conditions
Privacy Policy
Risk Warning

(C) 2007-2022 Fusion Media Limited. All Rights Reserved.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Related News